JPMorgan, Healthcare aktier

[Total Overview]


Seneste Kurs DKK (20-07-2017) 1920,59  

The objective of the JPMorgan Global Healthcare fund is to deliver long-term capital growth by investing primarily in pharmaceutical, biotechnology, healthcare services, medical technology and life sciences companies, globally. The healthcare sector has delivered attractive returns to investors over the last decade. The sector is well placed for further impressive growth, supported by ageing populations across many countries and growing healthcare spending in the emerging markets.Selectivity is key in identifying the winners in this diverse and often complex sector. At J.P. Morgan Asset Management we have a team of highly experienced, dedicated healthcare specialists with, on average, 15 years' industry experience. Our investment approach is based on bottom-up fundamental company research, with a focus on the long term valuation and earnings potential of each company. We have the flexibility to invest globally across the entire healthcare sector allowing us to capture the highest conviction insights of our dedicated team of analysts.
Daglige data ( pr. 20. jul 2017 ) Fonden Ref. indeks
Afkast i år 8,72% ---
Afkast seneste måned -0,80% ---
Afkast seneste 3 måneder 1,71% ---
Afkast seneste år 3,92% ---
Afkast seneste 3 år 36,65% ---
Afkast seneste 5 år 123,37% ---
Afkast siden fondsstart 295,13% ---

Indekseret kurs udvikling
Sammenligne med:



Reference Indeks MSCI World/HealthCare NR  
MSCI World Healthcare Index (Net)  

Generel Info
Fondsforvalterens navn på fonden JPM Healthcare A (acc) USD
Område Aktier Sektor
Reference Indeks MSCI World/HealthCare NR  
Hjemland Luxembourg
Porteføljemanager Scott Braunstein, Anne Marden
ÅOP - Årlige investeringsomkostninger i procent 2,08% (2013)
Fondskode LU0432979614
Emissionstillæg/Købstillæg 0,00%
Indløsningsfradrag 0,00%  
Fond startdato 02-10-2009
Skandia Link startdato 23-04-2013  
Pensionsbeskatnings sats 15,30%
Lav risiko -
Typisk lavt afkast
 Høj risiko -
Typisk højt afkast